Pages that link to "Q34057765"
Jump to navigation
Jump to search
The following pages link to Contributions to protection from Streptococcus pneumoniae infection using the monovalent recombinant protein vaccine candidates PcpA, PhtD, and PlyD1 in an infant murine model during challenge (Q34057765):
Displaying 7 items.
- Higher levels of mucosal antibody to pneumococcal vaccine candidate proteins are associated with reduced acute otitis media caused by Streptococcus pneumoniae in young children (Q35915846) (← links)
- Next generation protein based Streptococcus pneumoniae vaccines (Q37130191) (← links)
- A bivalent pneumococcal histidine triad protein D-choline-binding protein A vaccine elicits functional antibodies that passively protect mice from Streptococcus pneumoniae challenge (Q37473239) (← links)
- Insights into structure and activity of natural compound inhibitors of pneumolysin (Q37625776) (← links)
- Modeling Specific Antibody Responses to Natural Immunization to Predict a Correlate of Protection Against Infection Before Commencing a Clinical Vaccine Trial (Q40053752) (← links)
- Immunodominance in T cell responses elicited against different domains of detoxified pneumolysin PlyD1. (Q52365761) (← links)
- Development of Next Generation Streptococcus pneumoniae Vaccines Conferring Broad Protection (Q90461757) (← links)